Abstract: . . .  Outcome of coronary bypass surgery vs. coronary angioplasty in diabetic pa- tients with multivessel coronary artery disease. J Am Coll Cardiol 1998; 31: 109. 100.Carozza JP, Kuntz RE, Fishman RF, Bains DS. Restenosis after arte- rial injury caused by stenting in patients with diabetes mellitus. Ann Int Med 1993; 188: 3449. 101.Kastrati A, Schmig A, Elezi S, Schuhlen H, Dirschinger J, Hadamitzky M, Wehinger A, Hausleiter J, Walter H, Neumann FJ. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 1997; 30: 142836.  . . .
. . .  coronary bypass surgery vs. coronary angioplasty in diabetic pa- tients with multivessel coronary artery disease. J Am Coll Cardiol 1998; 31: 109. 100.Carozza JP, Kuntz RE, Fishman RF, Bains DS. Restenosis after arte- rial injury caused by stenting in patients with diabetes mellitus. Ann Int Med 1993; 188: 3449. 101.Kastrati A, Schmig A, Elezi S, Schuhlen H, Dirschinger J, Hadamitzky M, Wehinger A, Hausleiter J, Walter H, Neumann FJ. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 1997; 30: 142836. 102.Van . . .
. . .  function is impaired earlier in the evolution of diabetic cardiomyopathy? Diab Care 1994; 17: 6339. 64. Hilsted J. Pathophysiology in diabetic autonomic neuropathy: car- diovascular hormonal and metabolic studies. Diabetes 1982; 31: 7307. 65. Ziegler D, Gries FA. Diagnostik und Therapie der kardiovaskulren autonomen Neuropathie. Diabetes Stoffwechsel 1994; 3: 2231. 66. Devereux RB, Pickering TG. Relationship between the level, pattern and variability of ambulatory blood pressure and target organ dam- age in hypertension. J Hypertens 1991; 9 (Suppl 8): . . .
. . .  jr (eds). Diabetes mellitus. Elsevier, New York, Amsterdam, London, 1990; 24956. 34. Ostermann H, van de Loo J. Factors of the hemostatic system in diabetic patients: A survey of controlled studies. Haemostas 1986; 16: 386416. 35. Assmann G. Fettstoffwechselstrungen und koronare Herzkrank- heit. Primrprvention, Diagnostik und Therapie. Leitlinien fr die Praxis. MMV Medizin, Mnchen, 1988. 36. Koschinsky T, Bnting CE. Multiple Modifikationen von Lipoprote- inen bei Diabetes mellitus. Diab Stoffw 1994; 3: 42935. 37. Fontbonne A, Eschwege E, Cambien . . .
. . .  endothelial cells with elevated glucose concentration and native and glycosylated low density lipoproteins. Diabetologia 1984; 26: 21822. 43. Opie LH. The heart; physiology, metabolism, pharmacology, therapy. Grune & Stratton, New York, 1984; 11152. 44. Gasic S. Diabetische Herzkrankheit . In: Waldhusl W, Gries FA (Hrsg). Diabetes in der Praxis. Springer-Verlag, Berlin, Heidelberg, New York, 1996; 41932. 45. Bremer J. Carnitine-metabolism and function. Thyriol Rev 1983; 63: 142080. 46. Rodrigues B, McNeill JH. Functional evaluation of hearts upon . . .
--3000,5,300,3373,63971